Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
28/01/201506:00Business WireAcceleron Pharma to Present at Upcoming Investor Conferences in FebruaryNASDAQ:XLRNAcceleron Pharma Inc
22/01/201515:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
12/01/201506:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
12/01/201506:00Business WireAcceleron Pharma Outlines Corporate Objectives for 2015NASDAQ:XLRNAcceleron Pharma Inc
15/12/201407:00Business WireAcceleron Pharma Added to NASDAQ Biotechnology IndexNASDAQ:XLRNAcceleron Pharma Inc
12/12/201415:52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:XLRNAcceleron Pharma Inc
12/12/201415:38Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:XLRNAcceleron Pharma Inc
12/12/201415:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XLRNAcceleron Pharma Inc
12/12/201406:30Business WireAcceleron Pharma Appoints Dr. Francois Nader to its Board of DirectorsNASDAQ:XLRNAcceleron Pharma Inc
10/12/201406:30Business WireLuspatercept Data on Myelodysplastic Syndromes Selected for “Best of ASH” by the American Society of HematologyNASDAQ:XLRNAcceleron Pharma Inc
08/12/201413:00Business WireNew Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and ExpositionNASDAQ:XLRNAcceleron Pharma Inc
07/12/201411:00Business WireNew Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (A...NASDAQ:XLRNAcceleron Pharma Inc
24/11/201406:30Business WireAcceleron Pharma to Present at Upcoming Investor Conferences in DecemberNASDAQ:XLRNAcceleron Pharma Inc
13/11/201408:30Business WireSotatercept Data from the Phase 2a Clinical Trial in Hemodialysis Patients Presented at the American Society of Nephrology Ki...NASDAQ:XLRNAcceleron Pharma Inc
07/11/201408:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
07/11/201406:30Business WireAcceleron Pharma Reports Third Quarter 2014 Financial and Operational ResultsNASDAQ:XLRNAcceleron Pharma Inc
06/11/201408:32Business WireAcceleron Announces New Clinical Data Presentations at the 2014 American Society of Hematology Annual MeetingNASDAQ:XLRNAcceleron Pharma Inc
30/10/201406:30Business WireAcceleron Pharma to Host Third Quarter 2014 Financial Results Conference Call and Webcast on November 7, 2014NASDAQ:XLRNAcceleron Pharma Inc
29/10/201406:30Business WireAcceleron Pharma to Present at Upcoming Investor Conferences in NovemberNASDAQ:XLRNAcceleron Pharma Inc
23/10/201409:52Business WireAcceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney Week 2014NASDAQ:XLRNAcceleron Pharma Inc
22/10/201406:30Business WireAcceleron Announces Educational Webcast on Chronic Kidney Disease - Mineral and Bone DisorderNASDAQ:XLRNAcceleron Pharma Inc
14/10/201406:30Business WireAcceleron Initiates Phase 1 Clinical Trial with Innovative Muscle Drug ACE-083NASDAQ:XLRNAcceleron Pharma Inc
01/10/201406:30Business WireAcceleron to Host Educational Webcast on Beta-thalassemiaNASDAQ:XLRNAcceleron Pharma Inc
29/09/201406:30Business WireAcceleron to Webcast Presentation at Leerink Partners Rare Disease RoundtableNASDAQ:XLRNAcceleron Pharma Inc
23/09/201407:30Business WireAcceleron Provides Update on Externally Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian CancerNASDAQ:XLRNAcceleron Pharma Inc
16/09/201406:00Business WireAcceleron to Host Educational Webcast Series with Clinical Thought LeadersNASDAQ:XLRNAcceleron Pharma Inc
27/08/201406:00Business WireAcceleron Pharma to Present at Upcoming Investor Conferences in SeptemberNASDAQ:XLRNAcceleron Pharma Inc
20/08/201415:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XLRNAcceleron Pharma Inc
12/08/201415:12Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:XLRNAcceleron Pharma Inc
12/08/201406:00Business WireAcceleron Pharma Reports Second Quarter 2014 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN

Su Consulta Reciente

Delayed Upgrade Clock